Cipla Ltd.

Cipla’s New Jersey-based unit -- Cipla USA, Inc is recalling 7,992 bottles of Difluprednate Ophthalmic Emulsion, used to treat swelling and pain after eye surgery, in the US market. The recalling of the lot is due to ‘lack of assurance of sterility’. There were complaints regarding ''defective container closure’. The affected lot was manufactured in India and marketed in the US by Cipla USA, Inc.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.